Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 4/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL776684 | 0.84 | SNCA (0.35) | CA2PTGDR2ALDH1A1HTTSNCA | |
| SCHEMBL2484125 | 0.82 | CA2 (0.37) | CA2PTGDR2ALDH1A1HTTSNCA | |
| SCHEMBL10377767 | 0.82 | ALDH1A1 (0.33) | CA2ALDH1A1HTTSNCAHSD17B10 | |
| SCHEMBL10596213 | 0.79 | ALDH1A1 (0.41) | CA2ALDH1A1HTTSNCACA1 | |
| SCHEMBL775756 | 0.79 | ALDH1A1 (0.35) | CA2ALDH1A1HTTSNCACA1 | |
| SCHEMBL7022009 | 0.78 | LMNA (0.33) | CA2PTGDR2ALDH1A1HTTSNCA | |
| SCHEMBL9419143 | 0.77 | ALOX15 (0.35) | CA2PTGDR2ALDH1A1HTTSNCA | |
| SCHEMBL775810 | 0.76 | TAAR1 (0.38) | CA2ALDH1A1HTTSNCACA1 | |
| SCHEMBL10598218 | 0.76 | SNCA (0.39) | CA2ALDH1A1HTTSNCACA1 | |
| SCHEMBL778772 | 0.75 | PTGS2 (0.38) | CA2PTGDR2ALDH1A1HTTSNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2347653-A2 | Animal ectoparasite control composition | Sumitomo Chemical Company, Limited (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-20110160251-A1 | ANIMAL ECTOPARASITE CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160251-A1 | ANIMAL ECTOPARASITE CONTROL COMPOSITION | ADIPOR1, ADIPOR2, PLIN3 | CA2 4179/4885PTGDR2 2247/4885ALDH1A1 2168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.